Skorupski Wojciech Jan, Kałużna-Oleksy Marta, Lesiak Maciej, Araszkiewicz Aleksander, Skorupski Włodzimierz, Grajek Stefan, Mitkowski Przemysław, Pyda Małgorzata, Grygier Marek
1st Department of Cardiology, Poznań University of Medical Sciences, 61-848 Poznań, Poland.
J Pers Med. 2022 Feb 25;12(3):348. doi: 10.3390/jpm12030348.
The study aims to evaluate the short- and long-term outcomes of left main percutaneous coronary interventions (LM PCI) in patients disqualified from coronary artery bypass graft surgery (CABG). We included 459 patients (mean age: 68.4 ± 9.4 years, 24.4% females), with at least 1-year follow-up; 396 patients in whom PCI was offered as an alternative to CABG (Group 1); and 63 patients who were disqualified from CABG by the Heart Team (Group 2). The SYNTAX score (29.1 ± 9.5 vs. 23.2 ± 9.7; p < 0.001) and Euroscore II value (2.72 ± 2.01 vs. 2.15 ± 2.16; p = 0.007) were significantly higher and ejection fraction was significantly lower (46% vs. 51.4%; p < 0.001) in Group 2. Patients in Group 2 more often required complex stenting techniques (33.3% vs. 16.2%; p = 0.001). The procedure success rates were very high and did not differ between groups (100% vs. 99.2%; p = 0.882). We observed no difference in periprocedural complication rates (12.7% vs. 7.8%; p = 0.198), but the long-term all-cause mortality rate was higher in Group 2 (26% vs. 21%; p = 0.031). LM PCI in patients disqualified from CABG is an effective and safe procedure with a low in-hospital complication rate. Long-term results are satisfactory.
本研究旨在评估冠状动脉旁路移植术(CABG)禁忌患者行左主干经皮冠状动脉介入治疗(LM PCI)的短期和长期疗效。我们纳入了459例患者(平均年龄:68.4±9.4岁,女性占24.4%),随访时间至少1年;其中396例患者接受PCI作为CABG的替代方案(第1组);63例患者被心脏团队判定为CABG禁忌(第2组)。第2组的SYNTAX评分(29.1±9.5 vs. 23.2±9.7;p<0.001)和欧洲心脏手术风险评估系统II值(2.72±2.01 vs. 2.15±2.16;p = 0.007)显著更高,射血分数显著更低(46% vs. 51.4%;p<0.001)。第2组患者更常需要复杂的支架置入技术(33.3% vs. 16.2%;p = 0.001)。手术成功率非常高,两组之间无差异(100% vs. 99.2%;p = 0.882)。我们观察到围手术期并发症发生率无差异(12.7% vs. 7.8%;p = 0.198),但第2组的长期全因死亡率更高(26% vs. 21%;p = 0.031)。CABG禁忌患者行LM PCI是一种有效且安全的手术,院内并发症发生率低。长期结果令人满意。